Sun Pharmaceutical Industries Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
4/10
|
40.29 | 56.11 | -28.2% | 41.83 | -3.68% |
| P/S |
|
8.08 | 17.79 | -54.6% |
|
|
| P/BV |
|
5.75 | 8.08 | -28.86% |
|
|
| P/FCF |
|
27.38 | -381.8 | -107.17% |
|
|
| Ev/Ebitda |
|
19.65 | 4.22 | 366.27% |
|
|
| Ev/S |
|
4.98 | 16.49 | -69.77% |
|
|
| Ev/FCF |
|
23.96 | -240.24 | -109.97% |
|
|
| E/P |
|
0.0352 | 0.0159 | 121.16% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
27.59 | -18.77 | -246.98% | 20.68 | +33.45% |
| ROE |
|
16.01 | 3.69 | 334.23% |
|
|
| ROA |
|
11.52 | 3.44 | 234.74% |
|
|
| ROIC |
|
18.19 | 11.26 | 61.5% |
|
|
| ROS |
|
20.05 | -47.96 | -141.81% |
|
|
| ROCE |
|
16.51 | 5.09 | 224.3% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.235 | 24.38 | -99.04% | 0.3533 | -33.48% |
| Nеt Debt/Ebitda |
|
-0.5318 | 21.3 | -102.5% |
|
|
| Debt/Ratio |
|
0.0333 | 0.126 | -73.56% |
|
|
| Debt/Equity |
|
0.2506 | 4.64 | -94.59% |
|
|
| Debt/Net Income |
|
0.2972 | -49.02 | -100.61% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.05/10
|
0.8206 | 0.6496 | 26.32% | 0.9061 | -9.44% |
| Number of years of dividend growth |
|
5 | 0.92 | 443.48% | ||
| DSI |
|
0.9286 | 0.8171 | 13.64% |
|
|
| Average dividend growth |
|
12.46 | 1.6 | 679.39% |
|
|
| Average percentage for 5 years |
|
0.9061 | 0.8856 | 2.32% |
|
|
| Average percentage for payments |
|
28.64 | 22.22 | 28.92% |
|
|
| Difference from average difference in sector |
|
0.171 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
45.44 | 72.87 | -37.64% | ||
| Growth impulse Ebitda in 5 years |
|
98.89 | 72.97 | 35.52% | ||
| Growth impulse Net Income in 5 years |
|
154.36 | 159.06 | -2.95% | ||
| Growth impulse FCF in 5 years |
|
98.16 | 85.7 | 14.54% | ||
| Growth impulse EPS in 5 years |
|
154.36 | 104.61 | 47.56% |
IP Score
7.06/10
